Navigation Links
Global Strategic Marketing Key to Success in Oncology Launches in the Pharmaceutical Sector
Date:10/28/2011

CHAPEL HILL, N.C., Oct. 28, 2011 /PRNewswire/ -- The oncology market continues to be a rapid growth area for the pharmaceutical industry. Managing all the aspects of successfully launching a new oncology product is a daunting endeavor that often falls to the Global Strategic Marketing function.

The regulatory environment, regional differences and the competitive nature of the oncology marketplace present significant challenges for Global Strategic Marketing (GSM) organizations. The evolving nature of these challenges pushes GSM organizations to continually assess their budgets, investment strategies, staffing, structure and scope of services.

For instance, a survey of 12 large pharmaceutical companies found a majority expected to increase spending for four of six GSM activities for pipeline products over the next two years. Activities expected to gain are ad boards, marketing, thought leaders and market intelligence. Meanwhile, most of the companies expect spending to stay flat or drop for global congresses/conventions during the same period, according to a new benchmarking study from Best Practices, LLC.

The study, Oncology Global Strategic Marketing: Benchmarking Budget Levels and Service Scope, was designed to help GSM leaders in oncology better evaluate and improve their global strategic marketing programs. This 75-page study provides current benchmarks such as:

  • GSM staffing benchmarks by role, by development phase, by number of oncology programs and per $100M in oncology sales
  • Outsourced and in-house labor dedicated to traditional and emerging markets
  • GSM organizational structure
  • Role of the GSM function for activities such as market intelligence, marketing, advocacy and KOL management
  • Spending benchmarks around key GSM activities within marketing, market intelligence and advocacy
  • Oncology GSM spending by phase of clinical development  

Pharma leaders who oversee or work in Global Strategic Marketing for Oncology can use this study to understand the investment levels, marketing activities, timing and structures needed to successfully steer products and pipeline programs through the complex oncology marketplace. The data are presented in two segments: large pharma and emerging companies.

A complimentary excerpt of the research report is available at: http://www3.best-in-class.com/rr1131.htm.

Research participants included Global Strategic Marketing leaders supporting oncology organizations at 17 companies, including 11 of the Top 25 pharma companies. The study included both large, established and small, emerging oncology companies to provide broadest insights.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations. For more information about Best Practices, LLC visit our Web site at www.best-in-class.com.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Hypertronics Partners with UBM Canon, the Leading Global Medical Device Industry Source, to Co-Host Strategies for Avoiding Device Failure Seminar
2. Global Pharm Announces the Closing of US$15 Million Redeemable Convertible Bonds Financing
3. Global Eyeglasses Industry
4. S*BIO to Initiate Global Phase 3 Clinical Trials of its Novel JAK2 Inhibitor Pacritinib for Treatment of Myelofibrosis (MF)
5. CPhI Global Portfolio Expands into South East Asia
6. Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume I 2011
7. MarketsandMarkets: Global Orthopedic Devices Market Expected to Reach $57.9 Billion by 2016
8. White Smile Global Inc. Proudly Announces the Introduction of a New Innovative White Smile® Professional™ Dental "In-Office" Teeth Whitening Kit
9. Intarcia and Quintiles Sign Letter of Intent for Innovative Global Collaboration to Advance ITCA 650 in Type 2 Diabetes
10. SPX to Acquire e&e, a Global Supplier of Extraction, Evaporation, Vacuum and Freeze Drying Technologies
11. Global Sources opens six trade shows with worlds top buyers registered to attend including Adidas, AEON, American Greetings, Brookstone, Casino, Coles Group, Mothercare, Next, Sears and Woolworths
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... March 22, 2017  CANTEL MEDICAL CORP. (NYSE: ... President and CEO, will be presenting at the 16 th ... Grand Central Hotel in New York . ... at 3:00 p.m. ET. In addition, management will be available ... A live audio webcast will be available via the investor ...
(Date:3/22/2017)... 2017  Ablation is the minimally invasive therapeutic ... of purposes, from cancerous or diseased tissue removal, ... in atrial fibrillation and others. The growing adoption ... to innovate and improvise existing ablation technologies for ... global market is expected to grow at high ...
(Date:3/22/2017)... LINCOLN, Mass. , March 22, 2017 /PRNewswire/ ... applying mechanistic modeling to drug research and development, ... QSP Day 2017.  QSP Day 2017 is a ... with the quantitative systems pharmacology (QSP) community. The ... mathematical modeling is de-risking and accelerating drug research ...
Breaking Medicine Technology:
(Date:3/22/2017)... NJ (PRWEB) , ... March 22, 2017 , ... ... Group, the nation’s leading digital and print media enterprise focused on cancer patients, ... video content, has released a special 12-part educational video series, “No Ifs, Ands, ...
(Date:3/22/2017)... ... March 22, 2017 , ... An intensive search of the ... HIV, reports Leslie Norins, MD, PhD. He says investigating this possibility, is ... Zika virus and in new infections with HIV. , His findings appear ...
(Date:3/22/2017)... (PRWEB) , ... March 22, 2017 , ... Last year, ... to a US Department of Agriculture report. While excess dairy can be caused ... a role. Lactose sensitivity is the inability to properly digest lactose, a sugar found ...
(Date:3/22/2017)... ... March 22, 2017 , ... The Vanderbeck Agency, a Long Island ... County region, is embarking on a combined charity effort with the Great Neck Breast ... last 25 years, the Great Neck Breast Cancer Coalition has worked to support breast ...
(Date:3/22/2017)... ... March 22, 2017 , ... The ... related services to families and business owners in the greater Nassau County area, ... & Lymphoma Society. , Every 3 minutes, someone in America is diagnosed with ...
Breaking Medicine News(10 mins):